<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Silva FLT</submitter><funding>Conselho Nacional de Desenvolvimento Científico e Tecnológico</funding><funding>Fundação de Amparo à Pesquisa do Estado de São Paulo</funding><funding>PRONON</funding><pagination>1428</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11577672</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>Pediatric sarcomas present heterogeneous morphology, genetics and clinical behavior posing a challenge for an accurate diagnosis. DNA methylation is an epigenetic modification that coordinates chromatin structure and regulates gene expression, determining cell type and function. DNA methylation-based tumor profiling classifier for sarcomas (known as sarcoma classifier) from the German Cancer Research Center (Deutsches Krebsforschungszentrum) was applied to 122 pediatric sarcomas referred to a reference pediatric oncology hospital. The classifiers reported 88.5% of agreement between histopathological and molecular classification confirming the initial diagnosis of all osteosarcomas and Ewing sarcomas. The Ewing-like sarcomas were reclassified into sarcomas with BCOR or CIC alterations, late</pubmed_abstract><journal>BMC cancer</journal><pubmed_title>Classification of pediatric soft and bone sarcomas using DNA methylation-based profiling.</pubmed_title><pmcid>PMC11577672</pmcid><funding_grant_id>SIPAR 25000.211368/2019-41</funding_grant_id><funding_grant_id>2021/06782-7</funding_grant_id><funding_grant_id>2022/04781-6</funding_grant_id><funding_grant_id>311141/2021-8</funding_grant_id><funding_grant_id>SIPAR 25000.012259/2019-42</funding_grant_id><pubmed_authors>Euzebio MF</pubmed_authors><pubmed_authors>Silva FLT</pubmed_authors><pubmed_authors>Franco MT</pubmed_authors><pubmed_authors>Zenatti PP</pubmed_authors><pubmed_authors>Jotta PY</pubmed_authors><pubmed_authors>Pereira LH</pubmed_authors><pubmed_authors>Ruas JS</pubmed_authors><pubmed_authors>Lucon DR</pubmed_authors><pubmed_authors>Cardinalli IA</pubmed_authors><pubmed_authors>Junqueira T</pubmed_authors><pubmed_authors>Maschietto M</pubmed_authors><pubmed_authors>Cassone AE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Classification of pediatric soft and bone sarcomas using DNA methylation-based profiling.</name><description>Pediatric sarcomas present heterogeneous morphology, genetics and clinical behavior posing a challenge for an accurate diagnosis. DNA methylation is an epigenetic modification that coordinates chromatin structure and regulates gene expression, determining cell type and function. DNA methylation-based tumor profiling classifier for sarcomas (known as sarcoma classifier) from the German Cancer Research Center (Deutsches Krebsforschungszentrum) was applied to 122 pediatric sarcomas referred to a reference pediatric oncology hospital. The classifiers reported 88.5% of agreement between histopathological and molecular classification confirming the initial diagnosis of all osteosarcomas and Ewing sarcomas. The Ewing-like sarcomas were reclassified into sarcomas with BCOR or CIC alterations, late</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-26T01:56:34.189Z</modification><creation>2025-04-06T10:18:52.175Z</creation></dates><accession>S-EPMC11577672</accession><cross_references><pubmed>39567898</pubmed><doi>10.1186/s12885-024-13159-9</doi></cross_references></HashMap>